BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36780696)

  • 1. Stereotactic body radiation therapy (SBRT) following Yttrium-90 (
    Mee SF; Polan DF; Dewaraja YK; Cuneo KC; Gemmete JJ; Evans JR; Lawrence TS; Dow JS; Mikell JK
    Phys Med Biol; 2023 Mar; 68(6):. PubMed ID: 36780696
    [No Abstract]   [Full Text] [Related]  

  • 2. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
    Snyder JE; Willett AB; Sun W; Kim Y
    Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
    Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
    J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
    Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
    Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates.
    Brosch J; Gosewisch A; Kaiser L; Seidensticker M; Ricke J; Zellmer J; Bartenstein P; Ziegler S; Ilhan H; Todica A; Böning G
    Phys Med; 2020 Dec; 80():317-326. PubMed ID: 33248338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of magnetic resonance imaging-guided liver stereotactic body radiation therapy: A comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based intensity modulated radiation therapy.
    Kishan AU; Cao M; Wang PC; Mikaeilian AG; Tenn S; Rwigema JM; Sheng K; Low DA; Kupelian PA; Steinberg ML; Lee P
    Pract Radiat Oncol; 2015; 5(5):330-337. PubMed ID: 25823383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential reduction of lung dose via VMAT with jaw tracking in the treatment of single-isocenter/two-lesion lung SBRT.
    Pokhrel D; Sanford L; Halfman M; Molloy J
    J Appl Clin Med Phys; 2019 May; 20(5):55-63. PubMed ID: 30955251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mono iso-centric VMAT planning for SBRT of multiple liver metastasis- A case report.
    Barik BK; Kumari J; Sahoo DK; Majumdar SKD; Barik SK; Das DK; Parida DK
    J Med Imaging Radiat Sci; 2023 Sep; 54(3):556-561. PubMed ID: 37455215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional liver-image guided hepatic therapy (FLIGHT): A technique to maximize hepatic functional reserve.
    Furukawa Y; Long DE; Ellsworth SG
    Med Dosim; 2020 Summer; 45(2):117-120. PubMed ID: 31439270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective internal radiation therapy of hepatic tumors: Morphologic and functional imaging for voxel-based computer-aided dosimetry.
    Skanjeti A; Magand N; Defez D; Tordo J; Rode A; Manichon AF; Hallouard F; Clave-Darcissac C; Dhomps A; Townsend DM; Rubello D; Giammarile F
    Biomed Pharmacother; 2020 Dec; 132():110865. PubMed ID: 33254427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model.
    Nakamura A; Prichard HA; Wo JY; Wolfgang JA; Hong TS
    J Appl Clin Med Phys; 2019 Feb; 20(2):71-83. PubMed ID: 30636367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose escalated liver stereotactic body radiation therapy at the mean respiratory position.
    Velec M; Moseley JL; Dawson LA; Brock KK
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1121-1128. PubMed ID: 25035217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
    Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma.
    Oladeru OT; Miccio JA; Yang J; Xue Y; Ryu S; Stessin AM
    J Gastrointest Oncol; 2016 Jun; 7(3):433-40. PubMed ID: 27284477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of using intravenous contrast-enhanced computed tomography (CT) scans in lung cancer treatment planning.
    Xiao J; Zhang H; Gong Y; Fu Y; Tang B; Wang S; Jiang Q; Li P
    Radiother Oncol; 2010 Jul; 96(1):73-7. PubMed ID: 20347496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose.
    Wilke L; Moustakis C; Blanck O; Albers D; Albrecht C; Avcu Y; Boucenna R; Buchauer K; Etzelstorfer T; Henkenberens C; Jeller D; Jurianz K; Kornhuber C; Kretschmer M; Lotze S; Meier K; Pemler P; Riegler A; Röser A; Schmidhalter D; Spruijt KH; Surber G; Vallet V; Wiehle R; Willner J; Winkler P; Wittig A; Guckenberger M; Tanadini-Lang S
    Strahlenther Onkol; 2021 Sep; 197(9):836-846. PubMed ID: 34196725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing feasibility of real-time ultrasound monitoring in stereotactic body radiotherapy of liver tumors.
    Zhong Y; Stephans K; Qi P; Yu N; Wong J; Xia P
    Technol Cancer Res Treat; 2013 Jun; 12(3):243-50. PubMed ID: 23369158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study.
    Su TS; Liu QH; Zhu XF; Liang P; Liang SX; Lai L; Zhou Y; Huang Y; Cheng T; Li LQ
    Radiat Oncol; 2021 Apr; 16(1):79. PubMed ID: 33882972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helical tomotherapy-based STAT stereotactic body radiation therapy: Dosimetric evaluation for a real-time SBRT treatment planning and delivery program.
    Dunlap N; McIntosh A; Sheng K; Yang W; Turner B; Shoushtari A; Sheehan J; Jones DR; Lu W; Ruchala K; Olivera G; Parnell D; Larner JL; Benedict SH; Read PW
    Med Dosim; 2010; 35(4):312-9. PubMed ID: 21055611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.